Jupiter Life Line Hospitals Limited — Investor Meet, 11-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

**Financial Performance:** Jupiter Life Line Hospitals reported a revenue of Rs. 322 crores for Q3 FY25, reflecting a 17.7% year-on-year increase. EBITDA reached Rs. 76.4 crores, up 21.5% YoY, with an EBITDA margin at 23.7%. PAT also improved to Rs. 52.5 crores, a 20.1% increase YoY, resulting in a PAT margin of 16.3%. For the nine-month period, revenue was Rs. 934.8 crores (19.5% YoY growth), with a PAT of Rs. 148.6 crores (13.2% YoY increase) and a consistent EBITDA margin of 23.4%.

**Future Outlook and Growth Drivers:** Management emphasized expansion plans, with the acquisition of land for a new hospital in Mira Road, which will increase bed capacity to approximately 2,500. The hospital will address the unmet healthcare needs of densely populated areas in the region. Additionally, the second hospital in Pune is set to commence construction soon, with the expectation of operationalizing new facilities progressively over the next few years.

**Order Book and Operational Updates:** The recently acquired Mira Road site will support a 300-bed facility with anticipated CAPEX of around Rs. 400 crores. The Pune hospital is expected to commence operations by calendar year 2028, and current projects are on track, including capacity expansions at existing hospitals.

**Analyst Q&A Insights:** During the Q&A, analysts queried about margin enhancement strategies, to which management highlighted price hikes, occupancy growth, and case mix optimization as key levers. Questions about competitive pressures in Thane revealed management's confidence in the existing demand, suggesting that market needs would dampen potential impacts from new entrants. Concerns about managing talent in a competitive market were addressed, reaffirming confidence due to a robust local doctor pool.

**Market or Regulatory Updates:** No significant regulatory updates were discussed that might alter operational strategies or financial outlook.

**Strategic Focus Areas:** The management's focus on efficient use of internal cash flows to fund expansions demonstrates fiscal prudence. Plans for sequential project rollouts indicate a deliberate approach to meet market demands while managing financial resources effectively.

**Investor Insight:** Given the solid financial performance, strategic expansion efforts, and strong market positioning, the company's trajectory aligns positively with growth potential, suggesting a favorable view for investors considering an entry or maintaining positions.